ProteinSimple Files For IPO

Santa Clara-based ProteinSimple has filed for an IPO, saying yesterday that it is looking to raised up to $86.25M in an IPO on the NASDAQ Global Select Market as PRTN. The startup--which develops protein analysis software and tools--is venture backed by Wellcome Trust, Essex Woodlands Health Ventures, Novo AS, Domain Associates, LVP Life Sciences Ventures, among others. The IPO is being underwritten by J.P. Morgan, BofA Merrill Lynch, Cowen and Company, and Leerink Partners.